ObvioHealth USA Inc. raised $31 million in its latest fundraising round, with $18.5 million originating from a partial Series B round, the company announced July 1. The investment allows ObvioHealth to invest further in its virtual clinical trial platform. It also will enable dozens of new hires this year, founder and CEO Ivan Jarry told Orlando Business Journal.